Abbott Laboratories stock: results due October 21 as it trades slightly lower pre-market
Published on 10/21/2026 at 08:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMorning agenda and market indication
- Abbott Laboratories is scheduled to release third-quarter results before the U.S. market opens on October 21, 2026.
- Benzinga's October 19, 2026, report described the release as pre-open.
- Abbott Laboratories stock trades pre-market at EUR 91.17 at 8:42 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.73 percent below the Xetra close of October 20, 2026.
Benzinga reported on October 19, 2026, that Abbott Laboratories would release its third-quarter results before the U.S. market open on October 21, 2026. Abbott Laboratories stock is at Lang & Schwarz at EUR 91.17 at 8:42 a.m. CEST on October 21, 2026, 0.73 percent below the Xetra close of October 20, 2026 (EUR 91.84).
Third-quarter results due today
The scheduled release is the next company-specific event for Abbott Laboratories and is due before regular trading begins in the United States, according to Benzinga.
Ahead of the Xetra open
The indication is EUR -0.67 versus that reference, placing the stock below the Xetra close. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Abbott's healthcare business
Abbott develops healthcare technologies and sells products such as the Lingo Glucose System in the healthcare market, which its website describes for adults who are not using insulin. The company’s scheduled results are the main dated item for the trading day. Market context: Market report S&P 500.
